AAAAAA

   
Results: 1-25 | 26-50 | 51-64
Results: 1-25/64
INFORMED CONSENT - EXPLICIT CONSENT IS NOT NEEDED FOR STUDIES USING MEDICAL RECORDS
Authors: BREWSTER DH BAIN MRS CHALMERS JWT GOULD A DEWAR JA GEORGE WD
Citation: Dh. Brewster et al., INFORMED CONSENT - EXPLICIT CONSENT IS NOT NEEDED FOR STUDIES USING MEDICAL RECORDS, BMJ. British medical journal, 317(7163), 1998, pp. 948-948
DUCTAL CARCINOMA IN-SITU - FACTORS AFFECTING RECURRENCE
Authors: HIEW LY STALLARD S PURUSHOTHAM AD MEHANA H CORDINER C DOBSON H MALLON EA GEORGE WD
Citation: Ly. Hiew et al., DUCTAL CARCINOMA IN-SITU - FACTORS AFFECTING RECURRENCE, European journal of cancer, 34, 1998, pp. 22-22
CONSERVATION SURGERY AND SPECIALIST TREATMENT
Authors: KINGSMORE DB HOLE D GILLIS GR GEORGE WD
Citation: Db. Kingsmore et al., CONSERVATION SURGERY AND SPECIALIST TREATMENT, European journal of cancer, 34, 1998, pp. 191-191
THE SPECIALIST TREATMENT OF THE AXILLA
Authors: KINGSMORE DB HOLE D GILLIS CR GEORGE WD
Citation: Db. Kingsmore et al., THE SPECIALIST TREATMENT OF THE AXILLA, European journal of cancer, 34, 1998, pp. 202-202
ARM MORBIDITY IN 131 WOMEN WITH SMALL BREAST-TUMORS (UP TO 10 MM) WHOALL HAD LEVEL-2 AXILLARY CLEARANCE
Authors: STALLARD S MALLON EA DOUGHTY JG KINGSMORE D MALLIK H HIEW L WATT C GEORGE WD
Citation: S. Stallard et al., ARM MORBIDITY IN 131 WOMEN WITH SMALL BREAST-TUMORS (UP TO 10 MM) WHOALL HAD LEVEL-2 AXILLARY CLEARANCE, European journal of cancer, 34, 1998, pp. 227-227
HORMONE REPLACEMENT THERAPY DOES NOT INFLUENCE PATHOLOGICAL STAGE OF BREAST-CANCER IN 1113 TUMORS
Authors: STALLARD S LITHERLAND J CORDINER C MALLON E DOBSON H GEORGE WD HOLE DJ
Citation: S. Stallard et al., HORMONE REPLACEMENT THERAPY DOES NOT INFLUENCE PATHOLOGICAL STAGE OF BREAST-CANCER IN 1113 TUMORS, European journal of cancer, 34, 1998, pp. 382-382
CAN POPULATION-BASED SCREENING REDUCE THE MORTALITY FROM BREAST-CANCER
Authors: KINGSMORE DB HOLE D GILLIS CR GEORGE WD
Citation: Db. Kingsmore et al., CAN POPULATION-BASED SCREENING REDUCE THE MORTALITY FROM BREAST-CANCER, European journal of cancer, 34, 1998, pp. 420-420
CAN THE MORTALITY OF BREAST-CANCER BE REDUCED
Authors: KINGSMORE DB HOLE D GILLIS CR GEORGE WD
Citation: Db. Kingsmore et al., CAN THE MORTALITY OF BREAST-CANCER BE REDUCED, European journal of cancer, 34, 1998, pp. 431-431
POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS
Authors: ABE O ABE R ENOMOTO K KIKUCHI K KOYAMA H NOMURA Y SAKAI K SUGIMACHI K TOMINAGA T UCHINO J YOSHIDA M BENRAADT J VANDEVELDE AO VANDONGEN JA VERMORKEN JB GIOKAS G LISSAIOS B HARVEY VJ HOLDAWAY TM KAY RG MASON BH COATES A FORBES JF FOCAN C LOBELLE JP GATES GD POWELL J DURAND M MAURIAC L BARTHOLOMEUS S PICCART MJ GELMAN RS HENDERSON IC SHAPIRO CL HANCOCK AK MASOOD MB PARKER D PRICE JJ JACKSON S RAGAZ J DELOZIER T MACELESECH J HAYBITTLE JL BERRY D BROADWATER G CIRRINCIONE C MUSS H NORTON L BAUM M HOUGHTON J RILEY D DENT DM GUDGEON CA HACKING A GORDON NH DAVIS HL ROMESTAING P LEHINGUE Y OWEN JR MEIER P HOWELL A RIBEIRO GC SWINDELL R ALBANO J DEOLIVEIRA CF GERVASIO H GORDILHO J CARSTENSEN B PALSHOF T JOHANSEN H KORZENIOWSKI S SKOLYSZEWSKI J PORTNOJ SM ANDERSEN KW AXELSSON CK BLICHERTTOFT M MOURIDSEN HT OVERGAARD M ROSE C CORCORAN N TRAMPISCH HJ COMIS RL DAVIDSON NE GRAY R ROBERT N TORMEY DC WOOD W CHETTY U FORREST P JACK W ROSSBACH J SYLVESTER RJ VANDEVELDE CJH CUNNINGHAM MP BONNETERRE J FUMOLEAU P NAMER M BASTERT G RAUSCHECKER H SAUER R SAUERBREI W SCHAUER A SCHUMACHER M DESCHRYVER A BELFIGLIO M MARI E NICOLUCCI A SCORPIGLIONE N YOSEF HMA MCARDLE CS SMITH DC LARA PC BOCCARDO F RUBAGOTTI A ERAZO A MEDINA JY IZUO M MORISHITA Y BENTLEY A DORAN Z FENTIMAN IS HAYWARD JL RUBENS RD KAUFMANN M JONAT W SCHEURLEN H VONFOURNIER D FOUNTZILAS G KLAFSTROM P BLOMQVIST C CUZICK J MARGREITER R CASTIGLIONE M CAVILLI F COLLINS J FORBES J GELBER RD GOLDHIRSCH A LINDTNER J PRICE KN RUDENSTAM CM SENN HJ BLISS JM CHILVERS CED COOMBES RC MARTY M BOROVIK R BRUFMAN G HAYAT H ROBINSON E WIGLER N PANNUTI F TAKASHIMA S YASUTOMI T SONOO H YAMASHITA J OGAWA M WELVAART K HUPPERETS PSGJ BONTE J TENGRUP I TENNVALLNITTBY L MARTIN P ROMAIN S INGLE JN SUMAN VJ BUZDAR AU SMITH T HAKES T WITTES R DELAHUERTA R SAINZ MG BONADONNA G DELVECCHIO M VALAGUSSA P VERONESI U DUBOIS JB BIANCO AR LIPPMAN ME PIERCE LJ SIMON R STEINBERG SM MYLES JD PATER JL PRITCHARD KI ANDERSON S BROWN A BRYANT J COSTANTINO J DIGNAM J FISHER B REDMOND C WIEAND S WOLMARK N JACKSON IM PALMER MK BENGTSSON NO LARSSON LG LYTHGOE JP KISSIN M HANNISDAL E VARHAUG JE NISSENMEYER R BLAMEY RW MITCHELL AK ROBERTSON JFR UEO H MATHE G MISSET JL ABUZAHRA HT CLARKE EA MCLAUGHLIN JR CLARK RM LEVINE M MORIMOTO K SAWA K TAKATSUKA Y GUNDERSEN S HAUERJENSEN M HOST H CROSSLEY E HARRIS A BEIGHTON A CLARKE M COLLINS R DAVIES C EVANS V GODWIN J GREAVES E HARWOOD C JACKSON D JAMES S LAU E MEAD G NAUGHTEN A PETO R TOOTH A RAMBERT P ASSELAIN B SALMON RJ VILCOQ JR ARRIAGADA R HILL C LAPLANCHE A LE MG SPIELMANN M COCCONI G DIBLASIO B CATALANO R CREECH RH BROCKSCHMIDT J COOPER MR ANDRYSEK O BARKMANOVA J FALKSON CI ABRAHAM M KLIJN JGM TREURNIETDONKER AD VANPUTTEN WLJ EASTON D POWLES TJ GAZET JC SEMIGLAZOV V DESHPANDE N DIMARTINO L DOUGLAS P LINDTNER A NOTTER G BRYANT AJS EWING GH KRUSHENKOSLOSKI JL GEORGE WD GOULD A STEWART HJ STRONER P MOLLER TR RYDEN S CARSTENSEN J HATSCHEK T SODERBERG M CARPENTER JT ALBAIN K CROWLEY J GREEN S MARTINO S OSBORNE CK RAVDIN PM RUTQVIST LE WALLGREN A HOLM LE THURLIMANN B BRENNER H HERCBERGS A YOSHIMOTO M DEBOER G PATERSON AHG MEAKIN JW PANZARELLA T NAJA A BAHI J REID M SPITTLE M SENANAYAKE F BERGH J HOLMBERG L SEVELDA P ZIELINSKY CC GNANT M JAKESZ R BUCHANAN RB CROSS M DUNN JA GILLESPIE WM KELLY K MORRISON JM LITTON A CHLEBOWSKI RT BEZWODA WR CAFFIER H
Citation: O. Abe et al., POLYCHEMOTHERAPY FOR EARLY BREAST-CANCER - AN OVERVIEW OF THE RANDOMIZED TRIALS, Lancet, 352(9132), 1998, pp. 930-942
INCREASED PROLIFERATIVE ACTIVITY AND P53 EXPRESSION IN NORMAL GLANDULAR BREAST-TISSUE AFTER RADIATION-THERAPY
Authors: POEZE M VONMEYENFELDT MF PETERSE JL GEORGE WD DEJONG JMA JAGER JJ THUNNISSEN FBJM
Citation: M. Poeze et al., INCREASED PROLIFERATIVE ACTIVITY AND P53 EXPRESSION IN NORMAL GLANDULAR BREAST-TISSUE AFTER RADIATION-THERAPY, Journal of pathology, 185(1), 1998, pp. 32-37
EXPRESSION OF GAP JUNCTION PROTEINS CONNEXIN-26 AND CONNEXIN-43 IN NORMAL HUMAN BREAST AND IN BREAST-TUMORS
Authors: JAMIESON S GOING JJ DARCY R GEORGE WD
Citation: S. Jamieson et al., EXPRESSION OF GAP JUNCTION PROTEINS CONNEXIN-26 AND CONNEXIN-43 IN NORMAL HUMAN BREAST AND IN BREAST-TUMORS, Journal of pathology, 184(1), 1998, pp. 37-43
ANALYSIS OF THE SURVIVAL ADVANTAGE TO SPECIALIST TREATMENT OF BREAST-CANCER
Authors: KINGSMORE DB HOLE D GILLIS CR GEORGE WD
Citation: Db. Kingsmore et al., ANALYSIS OF THE SURVIVAL ADVANTAGE TO SPECIALIST TREATMENT OF BREAST-CANCER, British Journal of Surgery, 85(5), 1998, pp. 713-713
THE SPECIALIST TREATMENT OF THE AXILLA
Authors: KINGSMORE DB SSEMWOGERERE A HOLE D GILLIS CR GEORGE WD
Citation: Db. Kingsmore et al., THE SPECIALIST TREATMENT OF THE AXILLA, British Journal of Surgery, 85, 1998, pp. 32-32
IS AXILLARY CLEARANCE MERITED IN ALL WOMEN WITH BREAST-CANCER
Authors: KINGSMORE DB SSEMWOGERERE A HOLE D GILLIS CR GEORGE WD
Citation: Db. Kingsmore et al., IS AXILLARY CLEARANCE MERITED IN ALL WOMEN WITH BREAST-CANCER, British Journal of Surgery, 85, 1998, pp. 43-44
CAN THE MORTALITY OF BREAST-CANCER BE REDUCED
Authors: KINGSMORE DB HOLE D GILLIS CR GEORGE WD
Citation: Db. Kingsmore et al., CAN THE MORTALITY OF BREAST-CANCER BE REDUCED, British Journal of Surgery, 85, 1998, pp. 146-146
EPIDERMAL GROWTH-FACTOR RECEPTOR AND C-ERBB2 EXPRESSION IN BREAST-CANCER PROGRESSION
Authors: CHONG D REEVES J COOKE T GEORGE WD MALLON E OZANNE B STANTON P
Citation: D. Chong et al., EPIDERMAL GROWTH-FACTOR RECEPTOR AND C-ERBB2 EXPRESSION IN BREAST-CANCER PROGRESSION, British Journal of Surgery, 85(11), 1998, pp. 1570-1571
THE SPECIALIST TREATMENT OF THE AXILLA
Authors: KINGSMORE DB SSEMWOGERERE A HOLE D GILLIS CR GEORGE WD
Citation: Db. Kingsmore et al., THE SPECIALIST TREATMENT OF THE AXILLA, British Journal of Surgery, 85, 1998, pp. 19-19
TUMOR BED ASSESSMENT IN DUCTAL CARCINOMA IN-SITU
Authors: HIEW LY PURUSHOTHAM AD STALLARD S CORDINER C DOBSON H MALLON EA GEORGE WD
Citation: Ly. Hiew et al., TUMOR BED ASSESSMENT IN DUCTAL CARCINOMA IN-SITU, British Journal of Surgery, 85, 1998, pp. 20-20
DEFINITIVE AXILLARY TREATMENT AND SURVIVAL OF NODE-POSITIVE WOMEN WITH BREAST-CANCER
Authors: KINGSMORE DB HOLE D GILLIS CR GEORGE WD
Citation: Db. Kingsmore et al., DEFINITIVE AXILLARY TREATMENT AND SURVIVAL OF NODE-POSITIVE WOMEN WITH BREAST-CANCER, British Journal of Surgery, 85, 1998, pp. 67-67
TUMOR BED POSITIVITY IN WOMEN UNDERGOING BREAST-CONSERVING SURGERY FOR PRIMARY BREAST-CANCER
Authors: MALIK HZ PURUSHOTHAM AD MACMILLAN RD MALLON ED HARNETT AN GEORGE WD
Citation: Hz. Malik et al., TUMOR BED POSITIVITY IN WOMEN UNDERGOING BREAST-CONSERVING SURGERY FOR PRIMARY BREAST-CANCER, British Journal of Surgery, 85, 1998, pp. 68-69
FISH-TAIL PLASTY AS A METHOD OF TREATING POSTMASTECTOMY DOG-EAR
Authors: DOUGHTY JC GEORGE WD
Citation: Jc. Doughty et Wd. George, FISH-TAIL PLASTY AS A METHOD OF TREATING POSTMASTECTOMY DOG-EAR, British Journal of Surgery, 85, 1998, pp. 68-68
QUANTITATION OF C-ERBB-2 IN PRIMARY BREAST-CANCER - GENE AMPLIFICATION IS NOT THE WHOLE PICTURE
Authors: CHONG D REEVES J COOKE T GEORGE WD MALLON E OZANNE B STANTON P
Citation: D. Chong et al., QUANTITATION OF C-ERBB-2 IN PRIMARY BREAST-CANCER - GENE AMPLIFICATION IS NOT THE WHOLE PICTURE, British Journal of Cancer, 78, 1998, pp. 70-70
EGFR AND C-ERBB-2 EXPRESSION IN BREAST-CANCER PROGRESSION
Authors: CHONG D REEVES J COOKE T GEORGE WD MALLON E OZANNE B STANTON P
Citation: D. Chong et al., EGFR AND C-ERBB-2 EXPRESSION IN BREAST-CANCER PROGRESSION, British Journal of Cancer, 78, 1998, pp. 71-71
QUANTITATION OF EGFR AND C-ERBB-2 EXPRESSION IN PREINVASIVE COMPARED TO INVASIVE BREAST-CANCER
Authors: CHONG D REEVES J COOKE T GEORGE WD MALLON E OZANNE B STANTON F
Citation: D. Chong et al., QUANTITATION OF EGFR AND C-ERBB-2 EXPRESSION IN PREINVASIVE COMPARED TO INVASIVE BREAST-CANCER, British Journal of Cancer, 78, 1998, pp. 176-176
QUANTITATION OF C-ERBB-2 IN PRIMARY BREAST-CANCER ALLOWS IDENTIFICATION OF A FURTHER POOR PROGNOSTIC GROUP
Authors: CHONG D REEVES J COOKE T GEORGE WD MALLON E OZANNE B STANTON P
Citation: D. Chong et al., QUANTITATION OF C-ERBB-2 IN PRIMARY BREAST-CANCER ALLOWS IDENTIFICATION OF A FURTHER POOR PROGNOSTIC GROUP, British Journal of Cancer, 78, 1998, pp. 177-177
Risultati: 1-25 | 26-50 | 51-64